Exercise Mimetics Ranked: Which Ones Actually Work?
Ca-AKG, urolithin A and MOTS-c tie at 6.5, and only the first two are things you can legally buy. SS-31 follows at 6.0. The bottom three score low…
- Urolithin A
- Ca-AKG
- MOTS-c
- SS-31
- +3 more
Best Interventions for Cellular Senescence, Ranked by Evidence
Every intervention Outliyr has scored for cellular senescence, ranked by its BioHarmony score for this use case rather than its overall rating. The number beside each name is how well that one thing works for cellular senescence; the tier beside it is what it is worth once safety, cost and effort are counted across everything else.
40 of 84 evaluated interventions score 3.0+ out of 10 for cellular senescence · 6 comparisons
Ranked for Cellular Senescence
Category
-
Senolytics
The cellular senescence use case earns 8.2/10 for Senolytics, anchored by Silva et al. 2024. Direct mechanism: Zhu 2015 identified senescent-cell anti-apoptotic pathway vulnerabilities; Zhu 2017 identified fisetin as senolytic in selected…
Read the Senolytics report → -
Rapamycin
Rapamycin cellular senescence earns 7.8/10 because Harrison 2009 anchors the most relevant signal. Rapamycin fits cellular senescence when mTORC1 modulation, autophagy, immune aging, or senescence biology is the actual target. The score…
Read the Rapamycin report → -
Glycine
Glycine cellular senescence earns 6.5/10 because Kumar 2023 anchors the most relevant signal. Glycine fits cellular senescence because glycine participates in sleep signaling, glutathione, collagen, methylation, and nervous-system balance, depending on the…
Read the Glycine report → -
Spermidine
The cellular-senescence case for Spermidine is 6.5/10 because Kiechl 2018 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Autophagy clears senescence-associated cellular damage in mechanistic and…
Read the Spermidine report → -
Molecular Hydrogen
Mechanistically, Molecular Hydrogen fits cellular senescence at 6.0/10 because Jamialahmadi 2024 reports 7 trials; reported reductions in total cholesterol, triglycerides, and LDL, with no significant HDL change. Ye 2026 points in the…
Read the Molecular Hydrogen report → -
Infrared Sauna
For cellular-senescence, Infrared Sauna lands at 6.0/10 because Hamaya 2025 supports the strongest part of the claim. The existing rationale points to this narrower claim: Heat-shock protein signaling may support protein folding…
Read the Infrared Sauna report → -
Red Light Therapy
Cellular-senescence lands at 5.8/10 because Red Light Therapy may improve mitochondrial function in stressed cells, but direct human senescence endpoints are missing. Hamblin 2017 supports inflammation and mitochondrial pathways that overlap with…
Read the Red Light Therapy report → -
Metformin
Metformin scores 5.8/10 for the cellular-senescence use case, based on modest preclinical data and limited clinical endpoints (UK Prospective Diabetes Study Group 1998). Metformin influences mTOR and AMPK pathways, which are linked…
Read the Metformin report → -
Ca-AKG (Calcium Alpha-Ketoglutarate)
A 5.8/10 for cellular-senescence fits Ca-AKG (Calcium Alpha-Ketoglutarate) because Demidenko 2021 supports direction more than certainty. The existing rationale points to this narrower claim: Frailty reduction suggests downstream aging-biology relevance, but there…
Read the Ca-AKG (Calcium Alpha-Ketoglutarate) report → -
Hyperbaric Oxygen Therapy
Hachmo 2020 supports reductions in immunosenescent blood cells after sixty hard-chamber sessions in older adults. Replication and clinical-outcome linkage are missing. Score above neutral but below strong-recommend because the evidence ecosystem is…
Read the Hyperbaric Oxygen Therapy report → -
High-Dose Melatonin
High-Dose Melatonin earns a cautious cellular-senescence score because oxidative stress, mitochondrial signaling, and oncology-adjuvant findings overlap with aging biology. Posadzki's umbrella review still flagged methodological heterogeneity across melatonin health outcomes (Posadzki et…
Read the High-Dose Melatonin report → -
Ketogenic Diet
The cellular senescence case for Ketogenic Diet lands at 5.5/10 because the evidence points to a plausible use case without proving a universal response. Leung GKW et al. 2025 is the best…
Read the Ketogenic Diet report → -
Methylene Blue
The cellular-senescence case for Methylene Blue is 5.5/10 because Rodriguez 2016 gives the most relevant evidence anchor. The existing rationale points to this narrower claim: Cellular-senescence rationale is preclinical and mitochondrial. Human…
Read the Methylene Blue report → -
Semaglutide
Cellular-senescence gets 5.5/10 because Semaglutide may reduce senescence pressure indirectly through weight loss, glycemic control, and lower inflammatory signaling. Perkovic 2024 supports organ-risk improvement in a metabolically high-risk group, but it does…
Read the Semaglutide report → -
Quercetin
Dasatinib plus quercetin reduced adipose and skin senescent-cell markers and SASP factors in 9 diabetic kidney disease patients within 11 days (Hickson 2019). Justice 2019 showed feasibility in IPF (n=14) with improved…
Read the Quercetin report → -
Essential Amino Acids
The strongest cellular senescence argument for Essential Amino Acids is 5.0/10 because Wittholz 2024 reports Systematic review found heterogeneity high enough that planned meta-analysis was not possible. Hughes 2024 points in the…
Read the Essential Amino Acids report → -
Neurofeedback
No direct senescence data. Neurofeedback changes brain-state regulation and behavior; it does not have trials showing senescent-cell reduction or senescence-marker change. Keep this low and indirect, tied only to cognitive preservation and…
Read the Neurofeedback report → -
GHK-Cu
Cellular senescence keeps a 4.5 because He 2024 reports aged-fibroblast and myofibroblast senescence mechanisms, and Pickart reviews discuss youthful gene-expression patterns. Human senescence-marker trials are missing.
Read the GHK-Cu report → -
Tirzepatide
Visceral fat reduction may lower senescence-associated inflammatory signaling indirectly; no direct senolytic activity is established.
Read the Tirzepatide report → -
Zone 2 Cardio
Regular aerobic exercise may reduce senescence-associated inflammatory burden through metabolic and immune pathways. Direct human evidence that Zone 2 clears senescent cells is not strong enough for a higher score.
Read the Zone 2 Cardio report → -
Whole-Body Vibration
No direct human senescence-marker evidence. Mechanical loading may improve tissue function, but senescence-specific claims should stay exploratory.
Read the Whole-Body Vibration report → -
Urolithin A
Damaged mitochondria are associated with cellular aging, so the mitophagy mechanism is relevant. Direct human senescence-marker evidence is still insufficient.
Read the Urolithin A report → -
SS-31 (Elamipretide)
Mitochondrial dysfunction drives senescence biology, but SS-31 has no direct human senescence-marker trial and should not be treated as a senolytic or proven senomorphic compound.
Read the SS-31 (Elamipretide) report → -
SLU-PP-332
Bonanni et al. 2025 found favorable ex vivo marker shifts around oxidative stress, senescence, and differentiation in human myoblast work. This supports exploration, not a human senescence intervention.
Read the SLU-PP-332 report → -
Norwegian 4×4
Exercise may reduce senescence burden in some tissues through metabolic and inflammatory pathways. Exact 4x4 senescence evidence remains mechanistic and indirect.
Read the Norwegian 4×4 report → -
Astaxanthin
Oxidative-stress reduction may reduce senescence pressure mechanistically. No direct human senescence-marker RCTs.
Read the Astaxanthin report → -
Epitalon
Telomerase activation and telomere effects point toward cellular-senescence relevance, but no human senescence-marker RCT exists. Khavinson 2003 and Al-dulaimi 2025 support cell-line mechanisms; they do not prove reduced p16, SASP, tissue aging,…
Read the Epitalon report → -
GlyNAC (Glycine + N-Acetylcysteine)
Cellular senescence was listed among the improved hallmarks in the older-adult RCT, but it is a mechanistic biomarker finding without independent replication. Scores 3.5/10.
Read the GlyNAC (Glycine + N-Acetylcysteine) report → -
Ergothioneine
Oxidative-stress reduction may ease senescence pressure mechanistically, but no human senescence-marker trial exists.
Read the Ergothioneine report → -
Fucoidan (Brown Seaweed Polysaccharide)
Mostly preclinical senescence-pathway signals; no human senescence-marker data.
Read the Fucoidan (Brown Seaweed Polysaccharide) report → -
NMN (Nicotinamide Mononucleotide)
NAD+ supports DNA repair and stress-response biology, but human senescence-marker trials are missing. The score reflects indirect rationale, not direct clearance of senescent cells.
Read the NMN (Nicotinamide Mononucleotide) report → -
Resveratrol
Cellular-senescence claims are mostly preclinical. Resveratrol can modulate stress-response pathways in cells and animals, but human trials have not shown reliable senescent-cell burden reduction, p16INK4a change, or SASP-marker improvement. The SIRT1 story…
Read the Resveratrol report → -
C15 (Pentadecanoic Acid)
The Cellular Fragility Syndrome framing is company-originated and has no independent diagnostic authority. Robinson 2024 (Robinson 2024) tested clinical biomarkers, not validated senescence markers such as p16INK4a, SASP cytokines, DNA-damage markers, or…
Read the C15 (Pentadecanoic Acid) report → -
Polyphenols (Dietary)
Cellular senescence is 3.0/10. Some flavonoids (fisetin, quercetin) have senolytic interest, but that is a specific-member story scored elsewhere, not the dietary class.
Read the Polyphenols (Dietary) report → -
Thymosin Alpha-1
Immune surveillance of senescent cells is a plausible pathway, but thymosin alpha-1 has no human senescence-marker trial. This remains a low-confidence healthspan extension angle.
Read the Thymosin Alpha-1 report → -
Berberine
Senescence signals are preclinical only. No human senescence marker, epigenetic clock, or tissue-aging trial supports berberine as a senolytic.
Read the Berberine report → -
NR (Nicotinamide Riboside)
NAD+ supports DNA repair and senescence-linked pathways, but direct human cellular-senescence outcomes remain indirect.
Read the NR (Nicotinamide Riboside) report → -
Celebrex (Celecoxib)
COX-2 contributes to inflammatory aging pathways and the senescence-associated secretory phenotype, but human senescence-marker trials do not justify celecoxib as a senolytic or longevity intervention.
Read the Celebrex (Celecoxib) report → -
TRT (Testosterone Replacement Therapy)
TRT has theoretical links to aging biology but no practical human senescence outcome evidence. It should not be framed as a senolytic, geroprotector, or cellular-aging reset.
Read the TRT (Testosterone Replacement Therapy) report → -
5-Amino-1MQ
5-Amino-1MQ reactivated senescent muscle stem cells in aged mice (Neelakantan 2019); no systemic senescence data in people.
Read the 5-Amino-1MQ report →
Nothing matches those filters.
Comparisons that judge cellular senescence
Head-to-head reports and category rankings that name a winner on this use case.
C15 vs Omega-3: Which Is Better for Heart Health?
No. Omega-3 scores 6.8 and C15:0 4.9, and the evidence gap is larger than the score gap. C15:0 has two small human trials. Omega-3 has outcome trials, prescription…
- C15
- Omega-3
Curcumin vs Quercetin: Which Is Better for Inflammation?
Different jobs, same shelf. Quercetin scores 6.8 and curcumin 6.5, which decides nothing. Curcumin wins joints, inflammatory markers, gut and mood. Quercetin wins allergies, blood pressure, uric acid…
- Curcumin
- Quercetin
HBOT vs Red Light Therapy: Which Is Better for Recovery?
Buy the panel. Red light therapy scores 8.0 against HBOT's 6.2, costs $17 to $43 a month against $3,000 to $6,000, and does not lose a single use…
- Hyperbaric Oxygen Therapy
- Red Light Therapy
Rapamycin vs Metformin: Which Is Better for Longevity?
Metformin scores 6.9 and rapamycin 6.8, which settles nothing. Rapamycin owns the aging-biology rows: longevity 8.0, autophagy 8.5, senescence 7.8, plus replicated mouse lifespan data. Metformin owns everyday…
- Rapamycin
- Metformin
Urolithin A vs NAD+: Which Is Better for Longevity?
Urolithin A scores 6.5 and direct NAD+ scores 5.0, and the gap is about human evidence rather than biology. Urolithin A has completed human trials with measured mitochondrial…
- Urolithin A
- NAD+
Questions about cellular senescence
What scores highest for cellular senescence?
Senolytics, at 8.2 out of 10 for cellular senescence. The cellular senescence use case earns 8.2/10 for Senolytics, anchored by Silva et al.
What is the cheapest thing that works for cellular senescence?
Of the top-scoring options, Glycine is the least expensive at about $2 a month, scoring 6.5 out of 10 for cellular senescence.
How many interventions has Outliyr scored for cellular senescence?
40 of the 84 interventions evaluated for cellular senescence score 3.0 out of 10 or better, which is the cut-off for appearing on this page.
